Lipid-based nano delivery of Tat-peptide conjugated drug or vaccine–promising therapeutic strategy for SARS-CoV-2 treatment
Mohammad Azam Ansari, Ahmad Almatroudi, Mohammad A. Alzohairy, Sami A. Alyahya, Mohammad N. Alomary, Hanan A. Al-Dossary, Saad Alghamdi
Abstract
KEYWORDS: COVID-19Sars-CoV-2pandemicTat-peptidesilver bulletlipid-based nanocarriersdrug deliveryvaccineoutbreak; Nanoformulations
Topics & Concepts
Coronavirus disease 2019 (COVID-19)DrugSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Drug delivery2019-20 coronavirus outbreakPharmacologyMedicinePeptideVirologyNanotechnologyChemistryMaterials scienceInfectious disease (medical specialty)Internal medicineDiseaseBiochemistryOutbreakRNA Interference and Gene DeliverySARS-CoV-2 and COVID-19 ResearchImmunotherapy and Immune Responses